Skip to main content
SpringerLink
Log in

Dose-intensive, Time-compressed Procarbazine, CCNU, Vincristine (PCV) with Peripheral Blood Stem Cell Support and Concurrent Radiation in Patients with Newly Diagnosed High-grade Gliomas

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The dose intensity of the PCV regimen can be doubled using peripheral blood stem cell (PBSC) support. This study sought to determine the feasibility of giving dose-intensive PCV concurrently with radiation therapy. Twelve patients, age 3.2–22.7 years, median 7.5 years, with newly diagnosed high grade gliomas were enrolled. Diagnoses included diffuse intrinsic brainstem gliomas (BSG) (n=6), glioblastoma (n=4), anaplastic astrocytoma (n=2). PBSCs were harvested prior to chemotherapy with G-CSF priming. Chemotherapy consisted of CCNU 130 mg/m2 and vincristine 1.5 mg/m2 on day 0, and procarbazine 150 mg/m2 on days 1–7. PBSCs were reinfused on day 9 of each course. Four courses of chemotherapy were administered every 28 days or when blood counts recovered. The first course was administered the week prior to RT, the second course began on week 3 of RT and the third and fourth course were given after RT. Hematologic toxicity was mild and the majority of courses were given on schedule. Five of six patients with diffuse BSG showed clinical improvement and three showed a radiographic response; however, only one remains alive 12+ months from diagnosis. All four patients with non-brainstem large-volume tumors showed clinical deterioration and radiographic progression during or shortly after RT. MRI scans showed massive edema and enhancement. Median time to radiographic progression was five months. Median overall survival was 11 months. We conclude that dose-intensive, time-compressed PCV given concurrently with large-volume RT appears to result in unacceptable toxicity in patients with large residual tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Freeman CR, Krischer JP, Sanford A, Cohen ME, Burger PC, Del Carpio R, Halperin EC, Munoz L, Friedman HS, Kun LE: Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study. Int J Radiat Oncol Biol Phys 27: 197–206, 1993

    PubMed  Google Scholar 

  2. Finlay JL, Boyett JM, Yates AJ, Wisoff JK, Milstein JM, Geyer JR, Bertolone SJ, McGuire P, Cherlow JM, Tefft M, Turski PA, Wara WM, Edwards M, Sutton LN, Berger MS, Epstein F, Ayers G, Allen JC. Packer RJ: Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine and prednisone with the eightdrugs-in-1–day regimen. J Clin Oncol 13: 112–123, 1995

    PubMed  Google Scholar 

  3. Sposto R, Ertel IJ, Jenkin RDT, Boesel CP, Venes JL, Ortega JA, Evans AE, Wara W, Hammond D: The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J Neuro-Oncol 7: 165–177, 1989

    Google Scholar 

  4. Levin VA, Silver P, Hannigan J, Wara WM, Gutin PH, Davis RL, Wilson CB: Superiority of postradiotherapy adjuvant chemotherapy with CCNU, procarbazine and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report. Int J Radiat Oncol Biol Phys 18: 321–324, 1990

    PubMed  Google Scholar 

  5. Hryniuk W: The importance of dose-intensity in the outcome of chemotherapy. In: DeVita VT Jr, Helman S, Rosenberg SA (eds): Important Advances in Oncology. Lippincott, Philadelphia, PA, 1989, pp 121–141

  6. Jakacki RI, Jamison C, Mathews VP, Heilman DK, Dropcho E, Cornetta K, Macdonald DR, Williams DA: Dose-intensification of procarbazine, CCNU, vincristine (PCV) with peripheral blood stem cell support in young patients with gliomas. MedPediatr Oncol 31: 483–490, 1998

    Google Scholar 

  7. Siemann DW, Hill SA: Enhanced tumor response through therapies combining CCNU, miso and radiation. Int J Radiat Oncol Biol Phys l0: 1623, 1984

    Google Scholar 

  8. Wheeler KT, Deen DF, Wilson CB, Williams ME, Sheppard S: BCNU modification of the in vitro radiation response. Int J Radiat Oncol Biol Phys 2: 79–88 1977

    PubMed  Google Scholar 

  9. Gnekow AK: Recommendations of the Brain Tumor Subcommittee for the reporting of trials. Med Ped Oncol 24: 104–108, 1995

    Google Scholar 

  10. Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CG, Gehan EA, Strike TA: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic glioma: a cooperative clinical trial. J Neurosurg 49: 333–343, 1978

    PubMed  Google Scholar 

  11. Walker MD, Green SB, Byar DP, Alexander E, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Owens G, Ransohoff J, Robertson JT, Shapiro WR, Smith KR, Wilson CG, Strike TA: Randomized comparison of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. NEJM 303: 1323–1329, 1980

    PubMed  Google Scholar 

  12. Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y: Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A Joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group Study. Cancer 52: 997–1007, 1983

    PubMed  Google Scholar 

  13. Ushio T, Hayakawa T, Hasegawa H, Yamada K, Arita N: Chemotherapy of malignant gliomas. Neurosurg Rev 7: 3–12, 1984

    PubMed  Google Scholar 

  14. Eyre HJ, Quagliana JM, Eltringham JR, Frank J, O'Bryan RM, McDonald B, Rivkin SE: Randomized comparison of radiotherapy and CCNU versus radiotherapy, CCNU plus procarbazine for the treatment of malignant gliomas following surgery. J Neuro-Oncol l: 171–177, 1983

    Google Scholar 

  15. Comella G, Scoppa G, De Marco M, lanniello GP, Melillo G, Coucourde F and Zarrilli D: Radiotherapy and combination chemotherapy with carmustine, vincristine and procarbazine in primary brain tumors. J Neuro-Oncol 3: 13–17, 1985

    Google Scholar 

  16. Stewart DJ, Leavens M, Maor M, Feun L, Luna M, Bonura J, Caprioli R, Loo TL, Benjamin RS: Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors. Cancer Res 42: 2474–2479, 1982

    PubMed  Google Scholar 

  17. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho F, Stewart D, Schold C Jr., Wainman N, Eisenhauser E: Chemotherapy for anaplastic oligodendroglioma. J Clin Oncol 12: 2013–2021, 1994

    PubMed  Google Scholar 

  18. Postma TJ, van Groeningen CJ, Witjes RJGM, Weerts JGE, Kralendonk JH, Heimans JJ: Neurotoxicity of combination chemotherapy with procarbazine, CCNU and vincristine (PCV) for recurrent glioma. J Neuro-Oncol 38: 69–75, 1998

    Google Scholar 

  19. Griffin TW, Rasey JS, Bleyer WA: The effect of photon irradiation on blood-brain barrier permeability to methotrexate in mice. Cancer 40: 1109–1111, 1977

    Google Scholar 

  20. Hoagland HC: Hematologic complications of cancer chemotherapy. In: Perry MC (ed) The Chemotherapy Source Book.Williams andWilkins, Baltimore, MD, 1992, pp 498–502

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pediatric Neuro-Oncology, Department of Pediatrics, James Whitcomb Riley Hospital for Children, Indianapolis, IN, USA

    Regina I. Jakacki & Cheryl Jamison

  2. Department of Neurology, Beth Israel Medical Center North, New York, NY, USA

    Joao Siffert, Linda Velasquez & Jeffrey C. Allen

Authors
  1. Regina I. Jakacki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joao Siffert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Cheryl Jamison
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Linda Velasquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeffrey C. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jakacki, R.I., Siffert, J., Jamison, C. et al. Dose-intensive, Time-compressed Procarbazine, CCNU, Vincristine (PCV) with Peripheral Blood Stem Cell Support and Concurrent Radiation in Patients with Newly Diagnosed High-grade Gliomas. J Neurooncol 44, 77–83 (1999). https://doi.org/10.1023/A:1006360222643

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006360222643

Search

Navigation